TrialSignal
Clinical trial intelligence report
Proof of Concept of Pediatric and Adolescent EXPLORER V2 Exoskeleton in Children With Neurological and Neuromuscular Disease
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT05914818
Status
COMPLETED
Phase
Proof of Concept (Phase 0)
Sponsor
MarsiBionics
Executive brief
Investment-Ready Snapshot
MarsiBionics is developing the EXPLORER V2 exoskeleton aimed at assisting children with neurological and neuromuscular diseases in their daily activities. This clinical trial assesses the usability and safety of the device in real-world settings, which could enhance rehabilitation outcomes and market acceptance.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT05914818
Indication
Cerebral Palsy
Modality
medical device
Target
Pediatric and Adolescent EXPLORER V2 Exoskeleton
Intervention
EXPLORER V2
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.